Ursolaldehyde

Ursolaldehyde

SCHEMBL21183479

CC1(C)CCC2(C=O)CC[C@@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC[C@]43C)[C@@H]2C1

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 2/20 0.76
▸ PTPN1 P18031 10/20 0.72
▸ PTPN2 P17706 6/20 0.72
▸ PTPN6 P29350 4/20 0.72
▸ POLB P06746 3/20 0.72
▸ AKR1B10 O60218 3/20 0.72
▸ F3 P13726 3/20 0.72
▸ SIRT5 Q9NXA8 3/20 0.72
▸ PSMB11 A5LHX3 2/20 0.72
▸ PSMA7 O14818 2/20 0.72
▸ PLA2G1B P04054 2/20 0.72
▸ PTPRC P08575 2/20 0.72
▸ PTPRF P10586 2/20 0.72
▸ PSMB1 P20618 2/20 0.72
▸ CES1 P23141 2/20 0.72
▸ ACP1 P24666 2/20 0.72
▸ PSMA1 P25786 2/20 0.72
▸ PSMA2 P25787 2/20 0.72
▸ PSMA3 P25788 2/20 0.72
▸ PSMA4 P25789 2/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ursolaldehyde SCHEMBL18688153 1.00 USP2 (0.76) USP2PTPN1PTPN2PTPN6POLB
Ursolaldehyde SCHEMBL21149783 1.00 USP2 (0.76) USP2PTPN1PTPN2PTPN6POLB
Ursolaldehyde SCHEMBL1655258 1.00 USP2 (0.76) USP2PTPN1PTPN2PTPN6POLB
Ursolaldehyde SCHEMBL18625207 1.00 USP2 (0.76) USP2PTPN1PTPN2PTPN6POLB
SCHEMBL9882482 0.91 PTPN1 (0.62) USP2PTPN1PTPN2PTPN6POLB
SCHEMBL18689541 0.88 PTP4A3 (0.71) USP2PTPN1PTPN2PTPN6POLB
SCHEMBL16153033 0.88 PTPN1 (0.72) PTPN1PTPN2AKR1B10GPBAR1AKR1B1
Beta-Amyrin SCHEMBL18376076 0.86 USP2 (1.00) USP2PTPN1PTPN2PTPN6POLB
Beta-Amyrin SCHEMBL14226156 0.86 USP2 (1.00) USP2PTPN1PTPN2PTPN6POLB
Beta-Amyrin SCHEMBL377754 0.86 USP2 (1.00) USP2PTPN1PTPN2PTPN6POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11207333-B2 Compositions comprising triterpenoids and uses thereof for treating optic neuropathy REGENERA PHARMA LTD. (IL) 2021-12-28 — — US disclosed
US-20190224217-A1 COMPOSITIONS COMPRISING TRITERPENOIDS AND USES THEREOF FOR TREATING OPTIC NEUROPATHY REGENERA PHARMA LTD. (IL) 2019-07-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11207333-B2 Compositions comprising triterpenoids and uses thereof for treating optic neuropathy AQP4, CYP27A1, PMP22 USP2 4207/4885PTPN1 1922/4885PTPN2 1521/4885
US-20190224217-A1 COMPOSITIONS COMPRISING TRITERPENOIDS AND USES THEREOF FOR TREATING OPTIC NEUROPATHY AQP4, CYP27A1, PMP22 USP2 4207/4885PTPN1 1922/4885PTPN2 1521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback